American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.

ABSTRACT:

Background

Prevention and management of end-organ disease represent major challenges facing providers of children and adults with sickle cell disease (SCD). Uncertainty and variability in the screening, diagnosis, and management of cardiopulmonary and renal complications in SCD lead to varying outcomes for affected individuals.

Objective

These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about screening, diagnosis, and management of cardiopulmonary and renal complications of SCD.

Methods

ASH formed a multidisciplinary guideline panel that included 2 patient representatives and was balanced to minimize potential bias from conflicts of interest.

SUBMITTER: Liem RI 

PROVIDER: S-EPMC6963257 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature